Red Light Therapy for Brain Health: What the Science Says

Photobiomodulation (PBM) uses specific wavelengths of red and near-infrared light to enhance mitochondrial function, reduce neuroinflammation, and potentially improve cognitive performance. Originally used for wound healing and pain management, transcranial PBM is now being studied for traumatic brain injury, depression, and cognitive enhancement. The short answer: near-infrared light (around 800–850nm) does reach brain tissue through the skull, single laboratory sessions have improved attention and executive-function scores in small trials, and a 2023 review counted positive results in 29 of 35 human studies — but only about half of the clinical trials were randomised, and there is no long-term trial of home devices in healthy adults. Here is what the science supports and what remains speculative.

The Photobiomodulation Mechanism

Red light therapy works through a specific molecular target: cytochrome c oxidase (CCO), the terminal enzyme in the mitochondrial electron transport chain. When photons at wavelengths between 600-1100nm are absorbed by CCO, they dissociate inhibitory nitric oxide, allowing the enzyme to function more efficiently. This increases ATP production, modulates reactive oxygen species (ROS), and triggers secondary signaling cascades including NF-kB activation and increased BDNF expression.

Hamblin (2016) provided a comprehensive review showing that PBM at appropriate wavelengths and doses increases cerebral blood flow, reduces neuroinflammation, and promotes neurogenesis. The key word is "appropriate." Too little light has no effect; too much can paradoxically increase oxidative stress. This biphasic dose response (the Arndt-Schulz curve) makes dosing parameters critical.

Wavelengths: 660nm vs. 850nm

The two primary therapeutic wavelengths are 660nm (visible red) and 850nm (near-infrared, invisible). They serve different purposes for brain health:

660nm red light is used for superficial applications: skin health, wound healing, and surface-level inflammation. For brain health, 660nm alone is insufficient: in brain tissue it is absorbed and scattered more than near-infrared light, so far less of it gets to the cortex through scalp and skull.

Near-infrared light around 800–850nm penetrates significantly deeper. In eight human cadaver heads, an 808nm transcranial laser penetrated scalp, skull, meninges and brain to a depth of about 40mm, and inside brain tissue 808nm was absorbed and scattered less than either 660nm or 940nm (Tedford et al., 2015). Cadaver tissue is not living tissue, but it is the best direct measurement available. For transcranial applications targeting brain tissue, near-infrared is essential.

The ideal device for brain health combines both wavelengths: 660nm for surface tissue benefits and 850nm for transcranial penetration. Most quality panels offer a 50/50 combination.

Transcranial Protocols for Cognitive Enhancement

Transcranial photobiomodulation (tPBM) applies near-infrared light directly to the forehead, targeting the prefrontal cortex. The evidence for cognitive benefits in healthy adults is growing:

• Barrett and Gonzalez-Lima (2013): In 40 healthy volunteers, one session of 1064nm laser light to the forehead improved reaction time on a sustained-attention task and memory performance on a delayed match-to-sample task against placebo (Barrett and Gonzalez-Lima, 2013).
• Blanco et al. (2017): The same 1064nm laser reduced errors and improved set-shifting on the Wisconsin Card Sorting Test, a standard test of executive function, against placebo (Blanco et al., 2017).
• Transcranial LED case reports: Small case reports of transcranial LED therapy at 633nm and 870nm have described improved attention, memory, and executive function in traumatic brain injury patients, with effects reportedly persisting for months — early, low-powered evidence, not proof of a general cognitive benefit.
• Chan et al. (2019): In 30 older adults without a neuropsychiatric history, a single 7.5-minute session of LED light at 633nm and 870nm improved flanker and category-fluency scores compared with sham (Chan et al., 2019).
• Saltmarche et al. (2017): Five patients with mild to moderately severe dementia used 810nm, 10 Hz pulsed transcranial plus intranasal LED devices for 12 weeks. Their MMSE and ADAS-cog scores improved, and better sleep and less anxiety and wandering were reported — but there was no control group, scores fell sharply in the four weeks after treatment stopped, and one author founded the device company (Saltmarche et al., 2017).

Pooled, the picture is encouraging but soft. A systematic review of 35 human studies found positive cognitive results in 29, including all nine in people with memory complaints, mild cognitive impairment or dementia — but only about half of the clinical trials were randomised, and the most common clinical protocol used 810nm light at 20–25mW/cm2 (Lee et al., 2023). In young healthy adults, a meta-analysis of six studies found a large average improvement but high heterogeneity, modest study quality and signs of publication bias, and its authors said those problems must be solved before calling tPBM a cognitive enhancer (Salehpour et al., 2019). Some protocols pulse the light at 10 Hz or 40 Hz; whether that beats continuous light has not been settled.

Choosing a Device

None of the studies above used a consumer wellness panel — they used research lasers or clinical LED clusters — so no home device has trial evidence for cognition. If you buy one anyway, check three things on the manufacturer's own specification sheet rather than in marketing copy: that it includes near-infrared LEDs in the 800–850nm range (red alone will not reach the cortex); the irradiance in mW/cm2 at the distance you will actually use it, which is what lets you compare a session with the 20–25mW/cm2 common in clinical studies; and whether eye protection is supplied. Brands sold for home use include Joovv (full-size panels and the handheld Go) and Mito Red Light (the MitoPRO range); prices change often, so check them on the seller's own page.

Safety notes: wear the goggles the device comes with and do not look into the LEDs, especially the near-infrared ones you cannot see; ask a doctor first if you take a photosensitising medication, have a light-sensitive condition, or are pregnant. No device is a treatment for dementia, depression or brain injury.

What to Realistically Expect

A typical transcranial protocol uses daily 10-15 minute sessions with a 850nm (and often 660nm) device positioned a few inches from the forehead. Based on the published literature, here is the honest picture of what such a protocol may and may not do, which you can track with cognitive testing and HRV monitoring:

• Any reaction-time or alertness benefit in healthy young adults is, at best, modest — not a dramatic transformation — and the healthy-adult studies measured it in a laboratory, right after a single session.
• No trial cited here followed healthy adults using a home device for months, so a long-term benefit is an assumption, not a finding.
• There is little reason to expect a meaningful change in HRV or sleep from transcranial light alone.
• The strongest-looking results are in older adults and people with cognitive impairment, from small studies that still need randomised replication.

If you track it, use a fixed test at a fixed time of day and a baseline of at least two weeks before the first session — our walkthrough on how to track cognitive performance sets out a free protocol.

For where light therapy sits among other devices, see our beginner's guide to biohacking tools and the recovery and therapy hub.

If sleep quality is the outcome you are actually chasing, the supplement side is better evidenced than photobiomodulation is. Our magnesium for sleep guide compares the forms and the dose evidence behind each.

Contrarian take: The red light therapy industry is awash in overpromising. Claims about curing depression, reversing Alzheimer's, and dramatically enhancing cognition in healthy young adults are not supported by the current evidence base. Most positive studies involve older adults, TBI patients, or individuals with existing cognitive impairment. The effects in healthy young adults are modest at best — meaningful for some, but not life-changing. At $1,000+ for a quality panel, the return is questionable compared to spending that money on a year of nootropic supplementation or an Oura Ring for sleep tracking. Consider red light therapy after you have optimized sleep, nutrition, exercise, and supplementation, not before.

Disclaimer: This article is for informational purposes only and is not medical advice. Statements about supplements have not been evaluated by the Food and Drug Administration, and nothing here is intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before starting any supplement, device, or protocol.